COMPARTIR

Consumo de NRT (TRN) in Costa de Marfil

Multilingual database is in early beta - please report any issues you may have noticed.
Perfil
Ivory Coast Flag
Cigarrillos
Tradicional sin humo
HTP (PTC)
Cigarrillos electrónicos
Snus
Bolsas
NRT (TRN)
Ivory Coast Background
Perfil
Ivory Coast Flag
Cigarrillos
Tradicional sin humo
HTP (PTC)
Cigarrillos electrónicos
Snus
Bolsas
NRT (TRN)
Datos obtenidos: 2022.   Página actualizada: 2025-05-28

La terapia de reemplazo de nicotina (TRN) está permitida en Costa de Marfil. Por lo tanto, la venta y el uso de productos de TRN son legales, y su compra está permitida sin necesidad de receta médica. Aunque estos productos no están regulados como medicamentos, se encuentran disponibles en farmacias de todo el país. El gobierno ofrece un apoyo financiero parcial para la TRN, ya que estos productos están incluidos en la lista de medicamentos esenciales del país.

Regulación

Year Value Reference/Comment
2022 Permitidos 1A
2022 Permitidos 1A
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Year Value Reference/Comment
2022 No 1A
2022 No 1A
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.

Disponibilidad

Year Value Reference/Comment
2022 Sí 1A
2022 Sí 1A
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Year Value Reference/Comment
2019 Sí 1A
2022 Sí 1B
2022 Sí 1B
Referencias:
  1. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
  2. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Sí
2
2019
Year Value Reference/Comment
2019 Farmacia 1A
2022 Farmacia 1B
2022 Farmacia 1B
Referencias:
  1. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
  2. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
  2. WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).

Apoyo formal

Year Value Reference/Comment
2022 Sí NRT is not on the country's essential drugs list. 1A A
2022 Sí NRT is not on the country's essential drugs list. 1A A
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Comentarios:
  1. NRT cost is partially covered by the government.
Referencias:
  1. WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-civ.pdf?sfvrsn=55de85f_3&download=true. Accessed: 6 May 2025.
Comentarios:
  1. NRT cost is partially covered by the government.
The GSTHR database is updated regularly by our team. However, please be aware that the information we provide does not constitute legal advice. We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product categories can change at short notice and with little publicity. If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region, you should verify the information independently. If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details and any references and we will rectify any errors.